Finance

Lists
Why is LABS up 3,16%?
Dive Deeper
LABS:IDX
PT UBC Medical Indonesia Tbk
163,00 IDR
+3,16%
(+5,00) 1D
14 ოქტ, 16:13:51 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
158 IDR
High
163 IDR
Low
156 IDR
Mkt. cap
643,85 მლრ.
Avg. vol.
5,09 მლნ.
Volume
1,42 მლნ.
P/E ratio
60,23
52-wk high
260 IDR
52-wk low
129 IDR
EPS
3 IDR
Shares outstanding
3,95 მლრდ.
No. of employees
54
Open
158 IDR
High
163 IDR
Low
156 IDR
Mkt. cap
643,85 მლრ.
Avg. vol.
5,09 მლნ.
Volume
1,42 მლნ.
P/E ratio
60,23
52-wk high
260 IDR
52-wk low
129 IDR
EPS
3 IDR
Shares outstanding
3,95 მლრდ.
No. of employees
54
News stories
From web sources and news partners
About PT UBC Medical Indonesia Tbk
CEO-
Employees54
Founded2014
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
48,74 მლრდ.
63,86 მლრდ.
40,02 მლრდ.
55,20 მლრდ.
Cost of goods sold
27,68 მლრდ.
38,97 მლრდ.
21,51 მლრდ.
34,56 მლრდ.
Cost of revenue
27,68 მლრდ.
38,97 მლრდ.
21,51 მლრდ.
34,56 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,09 მლრდ.
16,63 მლრდ.
17,67 მლრდ.
14,25 მლრდ.
Operating expense
15,09 მლრდ.
17,40 მლრდ.
17,67 მლრდ.
14,25 მლრდ.
Total operating expenses
42,77 მლრდ.
56,38 მლრდ.
39,18 მლრდ.
48,81 მლრდ.
Operating income
5,97 მლრდ.
7,48 მლრდ.
843,68 მლნ.
6,39 მლრდ.
Other non operating income
97,39 მლნ.
-508,78 მლნ.
116,15 მლნ.
20,62 მლნ.
EBT including unusual items
4,91 მლრდ.
5,56 მლრდ.
409,62 მლნ.
3,83 მლრდ.
EBT excluding unusual items
4,91 მლრდ.
6,39 მლრდ.
409,62 მლნ.
3,83 მლრდ.
Income tax expense
-
4,02 მლრდ.
-
-
Effective tax rate
-
72,23%
-
-
Other operating expenses
-
-
-
-
Net income
4,91 მლრდ.
1,54 მლრდ.
409,63 მლნ.
3,83 მლრდ.
Net profit margin
10,07%
2,42%
1,02%
6,94%
Earnings per share
-
-
-
-
Interest and investment income
88,10 მლნ.
31,38 მლნ.
89,27 მლნ.
6,12 მლნ.
Interest expense
-275,82 მლნ.
-317,92 მლნ.
-229,81 მლნ.
-388,30 მლნ.
Net interest expenses
-187,72 მლნ.
-286,54 მლნ.
-140,54 მლნ.
-382,18 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
9,41 მლრდ.
9,77 მლრდ.
3,99 მლრდ.
9,17 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები